Development of photodynamic diagnosis and photodynamic therapy using 5-aminolevulinic acid for bone and soft tissue tumors.

Development of photodynamic diagnosis and photodynamic therapy using 5-aminolevulinic acid for bone and soft tissue tumors. - Development of photodynamic therapy for bone and soft tissue tumors.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017843

Enrollment

100

Registered

2015-07-01

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

one and soft tissue tumors

Interventions

Internal use of 5-aminolevulinic acid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis of bone and soft tissue tumor

Exclusion criteria

Exclusion criteria: No-consent

Design outcomes

Primary

Measure	Time frame
Recurrence rate	—

Countries

Japan

Contacts

Public ContactTaketo Okubo

Saitama Medical University International Medical Center Bone and soft tissue oncology

tohkubo@juntendo.ac.jp042-984-4111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026